A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Clinical trial NCT00482703 · COMPLETED

Trial details

NCT number: NCT00482703
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myeloid Leukemia, Chronic

Start date: 2007-05-01
Primary completion: 2009-05-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.